Dawn Biopharma has 2 portfolio companies on record at Recent Funding. Its most recent investment on record is Agomab Therapeutics's $95.45M Series B+ round in October 2023, alongside Walleye Capital, Redmile Group, Pontifax and 6 others. By category, its portfolio leans toward Health and bio (2).

What Dawn Biopharma invests in

• Health and bio · 2 · 100%

How Dawn Biopharma invests

Share is of the 1 round on Recent Funding that name Dawn Biopharma. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Dawn Biopharma portfolio companies

• AAgomab Therapeutics$95.45MSeries B+ · Oct 2023
• AAdcytherixbacker

Most frequent co-investors

• CCanaan Partners1 shared round · last Oct 11, 2023
• FFidelity1 shared round · last Oct 11, 2023
• AAsabys Partners1 shared round · last Oct 11, 2023
• EEQT Life Sciences1 shared round · last Oct 11, 2023
• CCormorant Asset Management1 shared round · last Oct 11, 2023
• RRedmile Group1 shared round · last Oct 11, 2023
• PPontifax1 shared round · last Oct 11, 2023
• WWalleye Capital1 shared round · last Oct 11, 2023
• PPfizer1 shared round · last Oct 11, 2023

Similar investors

• CCalm/Storm VC2 companies · 2 deals in 12 mo
• HHuatai Zijin Investment2 companies · 2 deals in 12 mo
• IIIMA Ventures2 companies · 2 deals in 12 mo
• SSound Bioventures2 companies · 2 deals in 12 mo
• TTenmile2 companies · 2 deals in 12 mo
• TThe FSE Group2 companies · 2 deals in 12 mo

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

Portfolio companies are the companies on Recent Funding with a round that lists Dawn Biopharma, which is a subset of its real portfolio. API: /api/v1/investors/dawn-biopharma (get a free API key). More: the most active VC firms and new venture capital funds.